TY - JOUR
T1 - The present and future of gastroenterology and hepatology
T2 - an international SWOT analysis (the GASTROSWOT project)
AU - de-Madaria, Enrique
AU - Mira, José J.
AU - Carrillo, Irene
AU - Afif, Waqqas
AU - Ang, Daphne
AU - Antelo, Marina
AU - Bollipo, Steven
AU - Castells, Antoni
AU - Chahal, Prabhleen
AU - Heinrich, Henriette
AU - Law, Joanna K.
AU - van Leerdam, Monique E.
AU - Lens, Sabela
AU - Pannala, Rahul
AU - Park, San Hyoung
AU - Rabiee, Atoosa
AU - Savarino, Edoardo V.
AU - Singh, Vikesh K.
AU - Vargo, John
AU - Charabaty, Aline
AU - Drenth, Joost P.H.
N1 - Publisher Copyright:
© 2022
PY - 2022/5
Y1 - 2022/5
N2 - GASTROSWOT is a strategic analysis of the current and projected states of the different subspecialties in gastroenterology that aims to provide guidance for research, clinical, and financial planning in gastroenterology. We executed a consensus-based international strengths, weaknesses, opportunities, and threats (SWOT) analysis. Four general coordinators, six field coordinators, and 12 experts participated in the study. SWOTs were provided for the following fields: neurogastroenterology, functional gastrointestinal disorders, and upper gastrointestinal diseases; inflammatory bowel disease; pancreatology and biliary diseases; endoscopy; gastrointestinal oncology; and hepatology. The GASTROSWOT analysis highlights the following in the current state of the field of gastroenterology: the incidence and complexity of several gastrointestinal diseases, including malignancies, are increasing; the COVID-19 pandemic has affected patient care on several levels; and with the advent of technical innovations in gastroenterology, a well trained workforce and strategic planning are required to optimise health-care utilisation. The analysis calls attention to the following in the future of gastroenterology: artificial intelligence and the use of big data will speed up discovery and smarter health-care provision in the field; the growth and diversification of gastroenterological specialties will improve specialised care for patients, but could promote fragmentation of care and health system inefficiencies; and furthermore, thoughtful planning is needed to reach an effective balance between the need for subspecialists and the value of general gastroenterology services.
AB - GASTROSWOT is a strategic analysis of the current and projected states of the different subspecialties in gastroenterology that aims to provide guidance for research, clinical, and financial planning in gastroenterology. We executed a consensus-based international strengths, weaknesses, opportunities, and threats (SWOT) analysis. Four general coordinators, six field coordinators, and 12 experts participated in the study. SWOTs were provided for the following fields: neurogastroenterology, functional gastrointestinal disorders, and upper gastrointestinal diseases; inflammatory bowel disease; pancreatology and biliary diseases; endoscopy; gastrointestinal oncology; and hepatology. The GASTROSWOT analysis highlights the following in the current state of the field of gastroenterology: the incidence and complexity of several gastrointestinal diseases, including malignancies, are increasing; the COVID-19 pandemic has affected patient care on several levels; and with the advent of technical innovations in gastroenterology, a well trained workforce and strategic planning are required to optimise health-care utilisation. The analysis calls attention to the following in the future of gastroenterology: artificial intelligence and the use of big data will speed up discovery and smarter health-care provision in the field; the growth and diversification of gastroenterological specialties will improve specialised care for patients, but could promote fragmentation of care and health system inefficiencies; and furthermore, thoughtful planning is needed to reach an effective balance between the need for subspecialists and the value of general gastroenterology services.
UR - http://www.scopus.com/inward/record.url?scp=85127506884&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127506884&partnerID=8YFLogxK
U2 - 10.1016/S2468-1253(21)00442-8
DO - 10.1016/S2468-1253(21)00442-8
M3 - Review article
C2 - 35247318
AN - SCOPUS:85127506884
SN - 2468-1253
VL - 7
SP - 485
EP - 494
JO - The Lancet Gastroenterology and Hepatology
JF - The Lancet Gastroenterology and Hepatology
IS - 5
ER -